mephenytoin has been researched along with Urinary Bladder Neoplasms in 1 studies
Mephenytoin: An anticonvulsant effective in tonic-clonic epilepsy (EPILEPSY, TONIC-CLONIC). It may cause blood dyscrasias.
mephenytoin : An imidazolidine-2,4-dione (hydantoin) in which the imidazolidine nucleus carries a methyl group at N-3 and has ethyl and phenyl substituents at C-5. An anticonvulsant, it is no longer available in the USA or the UK but is still studied largely because of its interesting hydroxylation polymorphism.
Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.
Excerpt | Relevance | Reference |
---|---|---|
"Patients with bladder cancer were classified on histological criteria as having aggressive (Stage III) (34%) or nonaggressive (Stages I and II) (66%) disease." | 5.27 | Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors. ( Branch, RA; Jaczq, E; Kaisary, A; McAllister, CB; Ray, WA; Smith, P; Wilkinson, GR, 1987) |
"Patients with bladder cancer were classified on histological criteria as having aggressive (Stage III) (34%) or nonaggressive (Stages I and II) (66%) disease." | 1.27 | Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors. ( Branch, RA; Jaczq, E; Kaisary, A; McAllister, CB; Ray, WA; Smith, P; Wilkinson, GR, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaisary, A | 1 |
Smith, P | 1 |
Jaczq, E | 1 |
McAllister, CB | 1 |
Wilkinson, GR | 1 |
Ray, WA | 1 |
Branch, RA | 1 |
1 other study available for mephenytoin and Urinary Bladder Neoplasms
Article | Year |
---|---|
Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors.
Topics: Acetylation; Aged; Alcohol Drinking; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytoch | 1987 |